VERV
Asset Logo

VERVE THERAPEUTICS INC

๐Ÿ‡บ๐Ÿ‡ธ NYSE/NASDAQ

Compare
Add to watchlist
๐Ÿ‘‘ Overview

๐Ÿ“ˆ Performance

๐Ÿ’ต Cost

๐Ÿƒ Esg

๐Ÿค“ Advanced

๐Ÿ‘จโ€๐Ÿ‘ฉโ€๐Ÿ‘งโ€๐Ÿ‘ฆ Community

๐Ÿ“ˆ

-22.94%
Annual Growth

3 years average annual growth

๐ŸŒ

1
Pearlers Invested

Since January 2020

๐Ÿ‘‘ Overview

Key information
๐Ÿ”Ž Fund Overview

Verve Therapeutics, Inc. is a clinical-stage genetic medicines company. The Company is focused on developing a new approach to the care of cardiovascular disease (CVD), transforming treatment from chronic management to single-course gene editing medicines. The Companyโ€™s lead programs include VERVE-101, VERVE-102, and VERVE-201, which target genes that have been validated as targets for lowering low-density lipoprotein cholesterol (LDL-C), a root cause of atherosclerotic cardiovascular disease (ASCVD). VERVE-101 and VERVE-102 are designed to permanently turn off the PCSK9 gene in the liver and are being developed initially for heterozygous familial hypercholesterolemia (HeFH). VERVE-201 is designed to permanently turn off the ANGPTL3 gene in the liver and is initially being developed for homozygous familial hypercholesterolemia (HoFH) and for refractory hypercholesterolemia where patients still have high LDL-C despite treatment with maximally tolerated standard of care therapies.

๐Ÿ“ˆ Performance

Price History*

-79.71%

1M

1Y

All Time

Graph

Table

* US price history does not take into account stock splits

Unsure how much or often to invest?
๐Ÿ—“๏ธ Investing frequency calculator

Determine the investment frequency needed to reach your goals

Try it out โ†’
๐Ÿ’ต Investing amount calculator

Determine the recurring investment needed to reach your goals

Try it out โ†’
โฑ๏ธ Investing duration calculator

Determine how long you will need to invest to reach your goals

Try it out โ†’

๐Ÿ’ต Costs

๐Ÿ’ต

6.50 AUD*
Purchase Fee

*$5.50 with Pearler Prepay

๐Ÿ’ผ

N/A
Management Fee

Included in unit price, not charged by Pearler

๐Ÿ’ธ

Want to know the long term costs?
Calculate the historic long term costs to hold your investments
๐Ÿ’ธ Net fee calculator

๐Ÿค“ Advanced information

Technical Info

๐Ÿ’ฐ Price*

$6.47

*Price may be up to 24 hours old

๐Ÿ‘ฉโ€๐Ÿ‘ฉโ€๐Ÿ‘ฆ Community Insights

How our community is investing

๐ŸŒ Pearlers invested in VERV

1

๐Ÿ“Š Total Capital Earnings

N/A

๐Ÿ”ƒ Average investment frequency

109 weeks

๐Ÿ’ต Average investment amount

$13,668

โฐ Last time a customer invested in VERV

66 days
VERV investor breakdown
๐Ÿ’ต Income of investors

More than 200k

150k - 200k

100k - 150k

50k - 100k

100%

Less than 50k

๐Ÿ‘ถ Age of investors

18 - 25

26 - 34

100%

35 - 90

๐Ÿ™‹ Legal gender of investors

Female

Male

100%

Pearlers who invest in VERV also invest in...

Editas Medicine Inc.

EDIT

๐Ÿ™Œ Performance (5Yr p.a)

-18.62%

๐Ÿ“Š Share price

$2.14 USD
Find Out More

๐Ÿ™Œ Performance (5Yr p.a)

-5.51%

๐Ÿ“Š Share price

$52.33 USD

๐Ÿ™Œ Performance (5Yr p.a)

39.20%

๐Ÿ“Š Share price

$165.43 USD

๐Ÿ“ˆ HIGH PRICE GROWTH

๐Ÿ™Œ Performance (5Yr p.a)

34.87%

๐Ÿ“Š Share price

$644.54 USD

๐Ÿ“ˆ HIGH PRICE GROWTH

๐Ÿ™Œ Performance (5Yr p.a)

30.02%

๐Ÿ“Š Share price

$352.70 USD

๐Ÿ“ˆ HIGH PRICE GROWTH

Want more shares? Try these...

๐Ÿ“Š Share price

$56.31 USD

๐Ÿ™Œ Performance (5Yr p.a)

-13.66%

๐Ÿ“Š Share price

$0.72 USD
Compare
Add to watchlist